The Zhongshan Angle Closure Prevention Trial

By the year 2020, primary angleclosure glaucoma (PACG) will account for half of the 11 million people who are estimated to be bilaterally blind from glaucoma.sup1/sup China is home to the majority of people with PACG worldwide. An estima...

Full Story →